GPT and fatty liver disease: Among the participants with MetS, 14% had elevated aspartate aminotransferase (AST), 22% had elevated alanine aminotransferase (ALT), 39.2% had elevated γ-glutamyltranspeptidase (GGT), and 78.3% had fatty liver.